4//SEC Filing
Parrish Jay 4
Accession 0001209191-21-001158
CIK 0001706431other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:40 PM ET
Size
8.8 KB
Accession
0001209191-21-001158
Insider Transaction Report
Form 4
Parrish Jay
Chief Business Officer
Transactions
- Exercise/Conversion
Common Stock
2021-01-04$1.49/sh+6,945$10,313→ 229,167 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-12-01−6,945→ 16,203 totalExercise: $1.49Exp: 2027-10-05→ Common Stock (6,945 underlying) - Sale
Common Stock
2021-01-04$26.32/sh−6,945$182,795→ 222,222 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020.
- [F2]1/4 of the shares subject to the stock option vested and became exercisable on April 3, 2018, and the remaining shares vest in 36 equal monthly installments thereafter.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0001786372
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:40 PM ET
- Size
- 8.8 KB